China-Based Panacea Venture Hits Final Close For New Healthcare Fund At $180.5M

Panacea Venture, a China-based venture capital firm backed by former partners of Kleiner Perkins Caufield & Byers China (KPCB China), has reached the final close of a new healthcare-focused fund "Panacea Venture Healthcare Fund I" with US$180.5 million in capital commitments.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

China Expert network